Assyro AI

FDA Orange Book · active-ingredient family

Oliceridine

Oliceridine is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:OLINVYK · NDA 210730

1

Brand (NDA)

0

Generics (ANDA)

5

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution

ProductApplicantApplicationTEApproved
OLINVYKRLD×3TREVENANDA 210730—Oct 30, 2020

Listed patents (5)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11931350Mar 23, 2032in 5 yr 10 mo
SubstanceU-2986
9642842Mar 23, 2032in 5 yr 10 mo
ProductU-2986
8835488Mar 23, 2032in 5 yr 10 mo
SubstanceProductU-2986
9309234Mar 23, 2032in 5 yr 10 mo
SubstanceProductU-2986
11077098Mar 23, 2032in 5 yr 10 mo
SubstanceProductU-2986

Oliceridine — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo